Oct. 11, 2019
Baltimore Marriott Inner Harbor at Camden Yards | 110 South Eutaw Street, Baltimore
Real-world evidence on treatment outcomes can be an important aspect of the evidence basis for decision making if it is seen as credible. For real-world studies that are meant to test hypotheses about comparative-effectiveness or safety, a key aspect of credibility is that they are conducted transparently with tests that follow a prespecified analytic protocol. Preregistration of such study protocols on a public website would help build trust that their results can be used for decision-making purposes.
This Summit will be a forum for discussion of the work of the Real-World Transparency Partnership, led by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), International Society for Pharmacoepidemiology (ISPE), Duke-Margolis Center for Health Policy, and the National Pharmaceutical Council, and involving a number of other organizations and stakeholders. It will focus on the key elements needed for the creation of a common registration site for these real-world studies that will be oriented for regular use by researchers and seen as a credible registry by decision-makers. The work already completed in this effort will be presented and the future steps envisioned will be discussed with Summit attendees.
To attend, register on the ISPOR Summit website.